KÄÄPÄ Biotech

KÄÄPÄ Biotech is a Finnish biotechnology company founded in 2018 and based in Karjalohja, Southern Finland.

It specializes in researching and developing innovative solutions using fungi, with a mission to promote healthier humans and ecosystems. Recognized as the largest medicinal mushroom grower in the European Union, KÄÄPÄ Biotech is a significant cultivator of Chaga mushrooms and operates with a commitment to sustainable and transparent practices. The company offers a range of services, including mycological research and development, carbon-free mushroom cultivation, and advanced extraction technology through its proprietary NordReleaseTM process. KÄÄPÄ Biotech produces various functional and medicinal mushroom products, such as Chaga, Lion's Mane, and Reishi, available in formats like extract powders, liquids, and tinctures. Its products are organic, EFSA-approved, and designed for health and wellness brands, food and beverage manufacturers, and pharmaceutical companies, among others. KÄÄPÄ Biotech is dedicated to environmental sustainability and community engagement, ensuring high-quality, bioactive products for its customers.